AltMountain

Blackstone Life Sciences VI L.P.

New York, NY · CIK 2023640

Blackstone Life Sciences VI L.P. is a private equity fund based in New York, New York. According to its most recent Form D, filed Apr 2, 2026, it has sold $6,300,000,000 of interests to 119 investors since its first sale in Dec 2024. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Omar Rehman; Victoria Portnoy; Christopher Striano.

Total raised
$6,300,000,000Cumulative sales reported on Form D
Investors
119
First sale
Dec 18, 2024
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Omar Rehman; Victoria Portnoy; Christopher Striano
Latest Form D
Apr 2, 2026

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌​‌⁠

Raise history

$6,300,000,000Dec 17, 2024: $0 raisedApr 23, 2025: $1,793,037,600 raisedOct 8, 2025: $3,292,836,493 raisedDec 9, 2025: $3,615,298,293 raisedApr 2, 2026: $6,300,000,000 raisedDec 2024Apr 2026
FiledFilingTotal raisedInvestorsSource
Apr 2, 2026Form D/A (amendment)$6,300,000,000119SEC.gov ↗
Dec 9, 2025Form D/A (amendment)$3,615,298,29369SEC.gov ↗
Oct 8, 2025Form D/A (amendment)$3,292,836,49367SEC.gov ↗
Apr 23, 2025Form D/A (amendment)$1,793,037,60049SEC.gov ↗
Dec 17, 2024Form D$00SEC.gov ↗

5 Form D filings in the SEC's electronic records (2008 onward), the earliest on Dec 17, 2024. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Vehicles of this fund (3)

Legal name on Form DSEC CIKLocation reportedTotal raisedInvestorsMinimumLatest Form D
Blackstone Life Sciences VI L.P. (main vehicle on this page)2023640New York, New York$6,300,000,000119$0Apr 2, 2026
Blackstone Life Sciences VI (LUX) SCSp2026410New York, New York$6,300,000,00023$0Apr 2, 2026
Blackstone Life Sciences VI - B L.P.2095970New York, New York$6,300,000,0001$0Apr 2, 2026

Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 3 filings carry the same name apart from such vehicle words or a series letter and report the same location or the same adviser, so AltMountain shows them on one page; the details above are those of Blackstone Life Sciences VI L.P., the vehicle reporting the most raised. Each row is that vehicle's own filing, exactly as filed. The amounts should not be added together, because a feeder's money can also be counted in its master fund. Grouped by AltMountain from the filings; not confirmed by the fund. The CIK links open each vehicle's filings on SEC.gov. Source: SEC Form D filings.

Raise history: Blackstone Life Sciences VI (LUX) SCSp

$6,300,000,000Dec 17, 2024: $0 raisedOct 8, 2025: $3,292,836,493 raisedDec 9, 2025: $3,615,298,293 raisedApr 2, 2026: $6,300,000,000 raisedDec 2024Apr 2026
FiledFilingTotal raisedInvestorsSource
Apr 2, 2026Form D/A (amendment)$6,300,000,00023SEC.gov ↗
Dec 9, 2025Form D/A (amendment)$3,615,298,29315SEC.gov ↗
Oct 8, 2025Form D/A (amendment)$3,292,836,49315SEC.gov ↗
Dec 17, 2024Form D$00SEC.gov ↗

4 Form D filings in the SEC's electronic records (2008 onward), the earliest on Dec 17, 2024. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Raise history: Blackstone Life Sciences VI - B L.P.

FiledFilingTotal raisedInvestorsSource
Apr 2, 2026Form D/A (amendment)$6,300,000,0001SEC.gov ↗
Nov 20, 2025Form D$3,615,298,2931SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Nov 20, 2025. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about Blackstone Life Sciences VI L.P.

What is the minimum investment for Blackstone Life Sciences VI L.P.?

Blackstone Life Sciences VI L.P.'s latest Form D, filed Apr 2, 2026, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Blackstone Life Sciences VI L.P.?

Blackstone Life Sciences VI L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Blackstone Life Sciences VI L.P. raised?

Blackstone Life Sciences VI L.P. reports $6,300,000,000 sold from 119 investors on its Form D filed Apr 2, 2026. This is cumulative sales since the offering began, not current assets or performance.

Where is Blackstone Life Sciences VI L.P. based?

Blackstone Life Sciences VI L.P. is based in New York, New York.

When did Blackstone Life Sciences VI L.P. launch?

Blackstone Life Sciences VI L.P. reports its first sale in Dec 2024.

Size compared with every private equity fund

Raised more than 99% of the 3,661 private equity funds based in New York, and more than 99% of all 8,931 that report sales.

Other funds with the same team

More private equity funds in New York

Similar-size private equity funds in New York

All private equity funds in New York